Trial Information

Summary: Maintainence of Benefit after 8 and 52-week Treatment for Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)

This is a medication trial in which all who qualify will receive a non-stimulant medication for ADHD and will be assessed for improvement in family functioning, academic performance, grade point average, and health outcomes.
Compensation Provided

Patient Inclusion/Exclusion Criteria:

Males and Females ages 13-16
Weight between 88 and 154 lbs.
Must meet criteria for ADHD
In good general health



Pregnant females
Adolescents who are doing well with their current ADHD treatment

Contact:

Robyn C Palmero, M.A.
Mount Sinai Medical Center
One Gustave L. Levy Place

New York, NY 10029
Telephone: 212-659-8833
Fax: 212-849-2690
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:43:49 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA